Orchard Therapeutics PLC (NASDAQ:ORTX)

4.80
Delayed Data
As of 3:59pm ET
 -0.14 / -2.83%
Today’s Change
4.46
Today|||52-Week Range
17.48
-65.09%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 15.00, with a high estimate of 26.00 and a low estimate of 13.00. The median estimate represents a +212.50% increase from the last price of 4.80.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$0.00
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.25%
 
 
 
 
 
 
Growthannually -2.41%
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -54.10%
 
 
 
 
Key to the earnings and sales forecast charts.